Cassie Burns, MD
Pain Medicine · Mobile, ALNPI 1053608224
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for pain medicine clinicians in AL, where the typical reported total is $1,761.
Across 70 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$344
- Medtronic$190
- Nevro Corp.$134
- Johnson & Johnson$117
- Boston Scientific$106
- Biotronik NRO, Inc.$86
- plus $463 from 18 others
What the payments were for
- Food & beverage$1,41498%
- Entertainment$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $344 |
| Medtronic(2 entities) | 11 | $190 |
| Nevro Corp. | 6 | $134 |
| Johnson & Johnson | 4 | $117 |
| Boston Scientific | 5 | $106 |
| Biotronik NRO, Inc. | 2 | $86 |
| Abbott | 4 | $85 |
| Lemaitre Vascular, Inc. | 4 | $59 |
| Baxter Healthcare | 2 | $58 |
| Flowonix Medical Incorporated | 1 | $27 |
| Averitas Pharma Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Kls-martin L.p. | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
| Valinor Pharma, LLC | 1 | $19 |
| Pfizer | 1 | $18 |
| Radius Health, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Irras USA, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Spinal Simplicity, LLC | 1 | $14 |
| Davol Inc. | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $11 |
| Stryker | 1 | $11 |
How this compares
$1,441 in reported general payments places this provider in the 45th percentile of 77 pain medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,196 | $51,611 |
| NucyntaTapentadol Hcl | 18 | $28,650 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 808 | $22,474 |
| LinzessLinaclotide | 34 | $20,975 |
| MovantikNaloxegol Oxalate | 39 | $19,721 |
| Lidocaine | 187 | $16,642 |
| Gabapentin | 1,419 | $14,831 |
| Diclofenac Sodium | 261 | $7,479 |
| Pregabalin | 447 | $6,367 |
| Buprenorphine | 12 | $5,754 |
| Tizanidine Hcl | 658 | $4,778 |
| Celecoxib | 187 | $3,768 |
| OxycontinOxycodone Hcl | 12 | $3,761 |
| Tramadol Hcl ErTramadol Hcl | 36 | $3,455 |
| Cyclobenzaprine Hcl | 422 | $2,952 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta | $23 | $28,65018 claims |
| AbbVieLinzess | $344 | $20,97534 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 77 pain medicine providers in Alabama.
Other pain medicine in Mobile
- Grant StoneMobile$11K
- Theodore KoppMobile$6K
- Tao ChenMobile$3K
- Anthony MaggioMobile$3K
- Ralph IrvinMobile$2K
- Christopher PaulBirmingham$64K
- Michael CosgroveHuntsville$25K
- Ron PitkanenMountain Brk$16K
- Elliott PenningtonDaphne$15K
- James ThackerHuntsville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.